{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:26:03Z","timestamp":1778617563298,"version":"3.51.4"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The 2022 multicountry mpox outbreaks predominantly affected gay, bisexual and other men who have sex with men (GBMSM) in non-endemic countries, including in the Netherlands. We conducted a survey-based assessment of the alignment between the risk factors associated with mpox diagnosis among GBMSM in the Netherlands and the eligibility criteria used in 2022 for vaccinating this group, with the aim to refine these criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An online self-report survey was conducted among adult GBMSM in the Netherlands between 29 July and 30 August 2022, corresponding to the first month of the Dutch mpox vaccination campaign. GBMSM were recruited via advertisements on social media and gay dating apps. Participants reported on their sexual behaviour, mpox diagnosis, and\/or (initial) mpox vaccination since the start of the outbreak. Covariables of mpox diagnosis and vaccination were assessed using logistic regression analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 2,460 participants, 73 (3.0%, 95% CI 2.3\u20133.6%) were diagnosed with mpox and 485 (19.7%, 95% CI 18.1\u201321.3%) had received (initial) mpox vaccination. Using sample weighting, we estimated that, of the GBMSM population aged 18\u201380\u2009years in the Netherlands, 1.1% (95% CI 0.7\u20131.6%) had been diagnosed with mpox and 7.8% (95% CI 6.8\u20138.9%) had received (initial) vaccination. HIV-PrEP use, living with HIV, reporting \u226520 sex partners in the past 12\u2009months, and sex in sex venues\/parties in the past 2\u2009months were independent risk factors for mpox diagnosis. Except for sex in sex venues\/parties, these variables were also independently associated with mpox vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provides novel evidence regarding the degree to which the 2022 eligibility criteria for mpox vaccination align with the risk factors for mpox among GBMSM in the Netherlands. The findings contribute to a refinement of the eligibility criteria for mpox vaccination, to which sex in sex venues\/parties should be added.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1194844","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T04:30:39Z","timestamp":1706589039000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A survey-based assessment of rates and covariates of mpox diagnosis and vaccination provides evidence to refine eligibility criteria for mpox vaccination among gay, bisexual and other men who have sex with men in the Netherlands"],"prefix":"10.3389","volume":"12","author":[{"given":"Philippe C. G.","family":"Adam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline L. M.","family":"Op de Coul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Zantkuijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Xiridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cor","family":"Blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsada","family":"Ketsuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet J. M.","family":"te Wierik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B. F.","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"ref1","year":"2023"},{"key":"ref2","first-page":"599","article-title":"Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man","volume":"46","author":"Marennikova","year":"1972","journal-title":"Bull World Health Organ"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1186\/s12879-022-07900-7","article-title":"Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease","volume":"22","author":"Sukhdeo","year":"2022","journal-title":"BMC Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","article-title":"The changing epidemiology of human monkeypox-a potential threat? A systematic review","volume":"16","author":"Bunge","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2200422","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422","article-title":"Community transmission of monkeypox in the United Kingdom, April to May 2022","volume":"27","author":"Vivancos","year":"2022","journal-title":"Euro Surveill"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries \u2013 April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2200620","DOI":"10.2807\/1560-7917.ES.2022.27.36.2200620","article-title":"A large multi-country outbreak of monkeypox across 41 countries in the WHO European region, 7 March to 23 August 2022","volume":"27","author":"Vaughan","year":"2022","journal-title":"Euro Surveill"},{"key":"ref8","year":"2023"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2200499","DOI":"10.2807\/1560-7917.ES.2022.27.27.2200499","article-title":"A shift from travel-associated cases to autochthonous transmission with Berlin as epicentre of the monkeypox outbreak in Germany, May to June 2022","volume":"27","author":"Selb","year":"2022","journal-title":"Euro Surveill"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.3201\/eid2810.220960","article-title":"Epidemiology of early monkeypox virus transmission in sexual networks of gay and bisexual men, England, 2022","volume":"28","author":"Vusirikala","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2200772","DOI":"10.2807\/1560-7917.ES.2023.28.12.2200772","article-title":"Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine","volume":"28","author":"van Ewijk","year":"2023","journal-title":"Eur Secur"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.15585\/mmwr.mm7140e3","article-title":"Incidence of monkeypox among unvaccinated persons compared with persons receiving \u22651 JYNNEOS vaccine dose \u2014 32 U.S. jurisdictions, July 31\u2013September 3, 2022","volume":"71","author":"Payne","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref13","volume-title":"Vaccines and immunisation for monkeypox. Interim guidance 16 November 2022","year":"2022"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.37201\/req\/059.2022","article-title":"Monkeypox in humans: a new outbreak","volume":"35","author":"Mart\u00edn-Delgado","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"E1560","DOI":"10.1503\/cmaj.221232","article-title":"Maximising the impact of limited vaccine supply under different early epidemic conditions: a 2-city modelling analysis of monkeypox virus transmission among men who have sex with men","volume":"194","author":"Knight","year":"2022","journal-title":"CMAJ"},{"key":"ref16","year":"2023"},{"key":"ref17","year":"2023"},{"key":"ref18","year":"2023"},{"key":"ref19","year":"2023"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad414","article-title":"The fading of the mpox outbreak among men who have sex with men: a mathematical modelling study","author":"Xiridou","year":"2023","journal-title":"J Infect Dis"},{"key":"ref21","year":"2023"},{"key":"ref22","year":""},{"key":"ref23","author":"Leenstra","year":"2022"},{"key":"ref24","volume-title":"Monkeypox multi-country outbreak \u2013 Second update, 18 October 2022","year":"2022"},{"key":"ref25","first-page":"11","article-title":"HIV in the Netherlands","volume-title":"Human immunodeficiency virus (HIV) infection in the Netherlands. Monitoring report 2022","author":"Van Sighem","year":"2023"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e0133232","DOI":"10.1371\/journal.pone.0133232","article-title":"Changing patterns of undiagnosed HIV infection in the Netherlands: who benefits most from intensified HIV test and treat policies?","volume":"10","author":"Op de Coul","year":"2015","journal-title":"PLoS One"},{"key":"ref27","first-page":"167","article-title":"Seksualiteit en seksuele gezondheid bij homo- en biseksuelen [Sexuality and sexual health of gay and bisexual persons]","volume-title":"Seksuele gezondheid in Nederland 2006","author":"Kuyper","year":"2006"},{"key":"ref28","year":"2023"},{"key":"ref29","year":"2022"},{"key":"ref30","author":"Van Dissel","year":"2022"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1194844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T04:30:43Z","timestamp":1706589043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1194844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":30,"alternative-id":["10.3389\/fpubh.2024.1194844"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1194844","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"article-number":"1194844"}}